LifeStance Health Q2 revenue $160.5M (+91% YoY), initiates FY2021 guidance

LifeStance Health Group, Inc.

Revenue $160.5M, up 91% YoY; net loss $70M includes $29.5M stock comp and $10M foundation endowment.
Adjusted EBITDA $14.5M (+39% YoY); total clinicians 3,975, up 94% YoY.
IPO completed June 10, net proceeds $548.9M used to retire debt and for corporate purposes.
FY2021 guidance: revenue $668M-$678M, Center Margin $198M-$208M, Adjusted EBITDA $47M-$53M.
Opened 35 de novo centers, entered 5 new states, completed 10 acquisitions in Q2.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.